All news
Oncoptic emerges to bring single-cell intelligence to cancer detection
A new deep-tech company is building an optical + AI platform to detect disease at the level of the individual cell.
Oncoptic is a deep-tech medical technology company developing a next-generation platform for advanced disease detection and cellular analysis.
By focusing on individual cell analysis, Oncoptic aims to provide deeper biological insights beyond traditional diagnostic approaches, enabling more precise and personalized healthcare solutions for blood cancer and other cellular-level disorders.